CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analog engineered for dramatically extended plasma half-life. The DAC modification allows albumin binding, extending biological activity across several days in preclinical models. Research examines sustained GH axis stimulation, IGF-1 elevation, and long-term effects on body composition and metabolic function. Studies have also explored its role in muscle protein synthesis, lipid metabolism, and recovery biomarkers. PeptideBull supplies CJC-1295 w/DAC at confirmed research-grade purity for authorized laboratory and preclinical research environments. Not intended for human consumption, self-administration, or therapeutic purposes.
Research Articles
CJC-1295 DAC Research: A Long-Acting GHRH Analog
Investigate CJC-1295 DAC, a synthetic GHRH analog with prolonged action. This article delves into its research mechanism...
CJC-1295 Ipamorelin Combination: GH Research Insights
Discover the science behind the CJC-1295 Ipamorelin combination for growth hormone research. Explore potential applicati...
CJC-1295 no DAC: Pulsatile Growth Hormone Research Insights
Discover the science behind CJC-1295 no DAC and its role in pulsatile growth hormone research. This article delves into...